Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: Toxicol Lett. 2012 Sep 8;214(3):314–319. doi: 10.1016/j.toxlet.2012.08.029

Fig. 4.

Fig. 4

COX-2 inhibitory activity of CBDA is not essential to attenuate MDA-MB-231 cell migration. Transwell migration assays were performed to determine the effects of COX-2 selective inhibitors (25 μM CBDA or 25 DuP-697) and COX-1selective inhibitor (25 μM SC-560) on MDA-MB-231 cell migration 12 h after their respective treatments. Data are expressed as the percent of vehicle-treated group (indicated as Cont.), as mean ± S.D. (n = 8). *Significantly different (p < 0.05) from the vehicle-treated control. N.D., not detectable due to complete inhibition of the migration.